CenturyLink Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

CenturyLink Investment Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,057	Closed	-$381K	–	248
2016 Q1	$381K	Sell	1,057 -2,182	-67%	-$899K	0.14%	174
2015 Q4	$1.76M	Buy	3,239 +351	+12%	+$190K	0.62%	41
2015 Q3	$1.34M	Buy	2,888 +38	+1%	+$20.4K	0.44%	80
2015 Q2	$1.45M	Sell	2,850 -212	-7%	-$103K	0.49%	78
2015 Q1	$1.38M	Sell	3,062 -494	-14%	-$209K	0.46%	84
2014 Q4	$1.46M	Buy	+3,556	New	+$1.4M	0.43%	88

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CenturyLink Investment Management's REGN Position: Q2 2016 in Review

CenturyLink Investment Management sold out of Regeneron Pharmaceuticals (REGN) in Q2 2016, closing a stake of 1,057 shares — an estimated $381K sold.

CenturyLink Investment Management first reported a position in REGN in Q4 2014 and held it in 6 quarters. The position peaked at $1.76M in Q4 2015. 542 funds tracked by Wall St. Rank hold REGN as of Q2 2016.

CenturyLink Investment Management reported no remaining Regeneron Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
CenturyLink Investment Management sold 1,057 Regeneron Pharmaceuticals shares in Q2 2016, an estimated $381K.
CenturyLink Investment Management first reported a position in Regeneron Pharmaceuticals in Q4 2014 and held it in 6 quarters.
CenturyLink Investment Management's Regeneron Pharmaceuticals position peaked at $1.76M in Q4 2015.
542 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2016.

Based on CenturyLink Investment Management's 13F filing for Q2 2016, filed 7 Jul 2016.